Emma Kalk, Alexa Heekes, Diane Lavies, Lizel Jacobs, Careni Spencer, Alison Boutall, Ayesha Osman, Chantal Stewart, Mary-Ann Davies, Anika van Niekerk, Karen Fieggen, Andrew Boulle, Ushma Mehta
{"title":"Population-based prevalence of congenital defects in a routine sentinel site-based surveillance system in the Western Cape, South Africa","authors":"Emma Kalk, Alexa Heekes, Diane Lavies, Lizel Jacobs, Careni Spencer, Alison Boutall, Ayesha Osman, Chantal Stewart, Mary-Ann Davies, Anika van Niekerk, Karen Fieggen, Andrew Boulle, Ushma Mehta","doi":"10.1002/bdr2.2388","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Lack of data on the burden and scope of congenital disorders (CDs) in South Africa undermines resource allocation and limits the ability to detect signals from potentially teratogenic pregnancy exposures.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We used routine electronic data in the Western Cape Pregnancy Exposure Registry (PER) to determine the overall and individual prevalence of CD identified on neonatal surface examination at birth in the Western Cape, South Africa, 2016–2022. CD was confirmed by record review. The contribution of late (≤24 months) and antenatal diagnoses was assessed. We compared demographic and obstetric characteristics between women with/without pregnancies affected by CD.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Women with a viable pregnancy (>22 weeks gestation; birth weight ≥ 500 g) (<i>n</i> = 32,494) were included. Of 1106 potential CD identified, 56.1% were confirmed on folder review. When internal and minor CD were excluded the prevalence of major CD identified on surface examination at birth was 7.2/1000 births. When missed/late diagnoses on examination (16.8%) and ultrasound (6.8%) were included, the prevalence was 9.2/1000 births: 8.9/1000 livebirths and 21.5/1000 stillbirths. The PER did not detect 21.5% of major CD visible at birth. Older maternal age and diabetes mellitus were associated with an increased prevalence of CD. Women living with/without HIV (or the timing of antiretroviral therapy, before/after conception), hypertension or obesity did not significantly affect prevalence of CD.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>A surveillance system based on routine data successfully determined the prevalence of major CD identified on surface examination at birth at rates slightly higher than in equivalent studies. Overall rates, modeled at ~2%, are likely underestimated. Strengthening routine neonatal examination and clinical record-keeping could improve CD ascertainment.</p>\n </section>\n </div>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"116 8","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bdr2.2388","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Birth Defects Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/bdr2.2388","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"DEVELOPMENTAL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Lack of data on the burden and scope of congenital disorders (CDs) in South Africa undermines resource allocation and limits the ability to detect signals from potentially teratogenic pregnancy exposures.
Methods
We used routine electronic data in the Western Cape Pregnancy Exposure Registry (PER) to determine the overall and individual prevalence of CD identified on neonatal surface examination at birth in the Western Cape, South Africa, 2016–2022. CD was confirmed by record review. The contribution of late (≤24 months) and antenatal diagnoses was assessed. We compared demographic and obstetric characteristics between women with/without pregnancies affected by CD.
Results
Women with a viable pregnancy (>22 weeks gestation; birth weight ≥ 500 g) (n = 32,494) were included. Of 1106 potential CD identified, 56.1% were confirmed on folder review. When internal and minor CD were excluded the prevalence of major CD identified on surface examination at birth was 7.2/1000 births. When missed/late diagnoses on examination (16.8%) and ultrasound (6.8%) were included, the prevalence was 9.2/1000 births: 8.9/1000 livebirths and 21.5/1000 stillbirths. The PER did not detect 21.5% of major CD visible at birth. Older maternal age and diabetes mellitus were associated with an increased prevalence of CD. Women living with/without HIV (or the timing of antiretroviral therapy, before/after conception), hypertension or obesity did not significantly affect prevalence of CD.
Conclusions
A surveillance system based on routine data successfully determined the prevalence of major CD identified on surface examination at birth at rates slightly higher than in equivalent studies. Overall rates, modeled at ~2%, are likely underestimated. Strengthening routine neonatal examination and clinical record-keeping could improve CD ascertainment.
背景:南非缺乏有关先天性疾病(CD)的负担和范围的数据,这有损于资源分配,并限制了检测潜在致畸妊娠暴露信号的能力:我们利用西开普省妊娠暴露登记处(PER)的常规电子数据,确定了 2016-2022 年南非西开普省出生时新生儿体表检查发现的先天性疾病的总体和个体患病率。CD通过记录审查得到确认。我们评估了晚期(≤24 个月)诊断和产前诊断的贡献。我们比较了受 CD 影响/未受 CD 影响的孕妇的人口和产科特征:结果:纳入了存活妊娠(妊娠期大于 22 周;出生体重≥ 500 克)的妇女(n = 32,494 人)。在确定的 1106 例潜在 CD 中,56.1% 经文件夹审查得到确认。排除内脏和轻微 CD 后,出生时体表检查发现的主要 CD 患病率为 7.2/1000。如果将检查(16.8%)和超声波检查(6.8%)的漏诊/迟诊计算在内,则发病率为 9.2/1000:8.9/1000 活产和 21.5/1000 死产。PER没有检测到21.5%的出生时可见的主要CD。高龄产妇和糖尿病与 CD 患病率增加有关。感染/未感染艾滋病毒的妇女(或接受抗逆转录病毒治疗的时间,受孕前/后)、高血压或肥胖对 CD 的患病率没有显著影响:基于常规数据的监测系统成功确定了出生时体表检查发现的主要 CD 患病率,其患病率略高于同等研究。根据模型计算的约 2% 的总体患病率很可能被低估了。加强新生儿常规检查和临床记录保存可提高 CD 的确定率。
期刊介绍:
The journal Birth Defects Research publishes original research and reviews in areas related to the etiology of adverse developmental and reproductive outcome. In particular the journal is devoted to the publication of original scientific research that contributes to the understanding of the biology of embryonic development and the prenatal causative factors and mechanisms leading to adverse pregnancy outcomes, namely structural and functional birth defects, pregnancy loss, postnatal functional defects in the human population, and to the identification of prenatal factors and biological mechanisms that reduce these risks.
Adverse reproductive and developmental outcomes may have genetic, environmental, nutritional or epigenetic causes. Accordingly, the journal Birth Defects Research takes an integrated, multidisciplinary approach in its organization and publication strategy. The journal Birth Defects Research contains separate sections for clinical and molecular teratology, developmental and reproductive toxicology, and reviews in developmental biology to acknowledge and accommodate the integrative nature of research in this field. Each section has a dedicated editor who is a leader in his/her field and who has full editorial authority in his/her area.